Free Trial

Evoke (LON:EVOK) Shares Down 10% - Should You Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Shares of Evoke plc (LON:EVOK - Get Free Report) dropped 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Wall Street Analyst Weigh In

Several brokerages recently issued reports on EVOK. Berenberg Bank decreased their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reiterated a "buy" rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th.

Check Out Our Latest Research Report on EVOK

Evoke Stock Performance

The stock has a market cap of £211.75 million, a PE ratio of -1.19 and a beta of 0.84. The business has a 50 day moving average price of GBX 68.36 and a two-hundred day moving average price of GBX 63.39.

Evoke (LON:EVOK - Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, research analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.90) per share, with a total value of £10,200.40 ($13,178.81). 27.00% of the stock is owned by insiders.

Evoke Company Profile

(Get Free Report)

Read More

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Is Marjorie Taylor Greene the next Nancy Pelosi when it comes to stock trading? After being appointed to the DOGE Committee, MTG made a significant Tesla stock purchase—raising questions about congres

Related Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads